Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kazuko Tani"'
Autor:
Yoshinobu Maruyama, Ken Ichi Ohyama, Hiroyuki Imanaka, Kazuhiro Nakanishi, Koreyoshi Imamura, Kazuko Tani, Toru Yokoyama
Publikováno v:
Spectroscopy Letters. 41:305-312
In an amorphous mixture of sugar and polyvinylpyrrolidone (PVP), PVP carbonyl groups form hydrogen bonds with sugar hydroxyl groups, thereby improving the physical stability of the amorphous matrix against a glass-to-rubber transition. Herein, Fourie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fab4b792cc91c818e5a43cdb832a735b
https://doi.org/10.1080/00387010802370959
https://doi.org/10.1080/00387010802370959
Health Care Resource Use Among Patients with Advanced Non–Small Cell Lung Cancer in Japan, 2017–2019
Autor:
Yasushi Goto, MD, PhD, Kodai Kawamura, MD, PhD, Tatsuro Fukuhara, MD, PhD, Yukiko Namba, MD, PhD, Keisuke Aoe, MD, PhD, Takehito Shukuya, MD, PhD, Takeshi Tsuda, MD, Melissa L. Santorelli, PhD, MPH, Kazuko Taniguchi, MS, Tetsu Kamitani, MD, PhD, Masato Irisawa, PhD, Kingo Kanda, MPharm, Machiko Abe, MS, Thomas Burke, PharmD, PhD, Hiroshi Nokihara, MD, PhD
Publikováno v:
Current Therapeutic Research, Vol 99, Iss , Pp 100712- (2023)
ABSTRACT: Background: First-line immune checkpoint inhibitor (ICI) monotherapy for advanced non–small cell lung cancer (NSCLC) was introduced in Japan in February 2017. Limited information is available since that time regarding health care resource
Externí odkaz:
https://doaj.org/article/56826401c91e4ca1b5e8511e8fa71b5f
Publikováno v:
Nihon Geka Gakkai zasshi. 113(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48e569e577344b095dac1f3bb4ac7806
https://pubmed.ncbi.nlm.nih.gov/22708394
https://pubmed.ncbi.nlm.nih.gov/22708394
Autor:
Yasushi Goto, MD, PhD, Atsuhisa Tamura, MD, PhD, Hirotaka Matsumoto, MD, Kazutoshi Isobe, MD, PhD, Tomohiro Ozaki, MD, Melissa L. Santorelli, PhD, MPH, Kazuko Taniguchi, MS, Tetsu Kamitani, MD, PhD, Masato Irisawa, PhD, Kingo Kanda, MPharm, Machiko Abe, MS, Thomas Burke, PharmD, PhD, Hiroshi Nokihara, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100397- (2022)
Introduction: Pembrolizumab became available in Japan in February 2017 for first-line monotherapy of unresectable advanced and metastatic NSCLC with programmed death-ligand 1 (PD-L1) tumor proportion score (TPS) greater than or equal to 50%. This ret
Externí odkaz:
https://doaj.org/article/6c1d51a111954179b8993ec6b3e61d62
Autor:
Katsunori Yanagihara, Kosuke Kosai, Hiroshige Mikamo, Hiroshi Mukae, Yoshio Takesue, Machiko Abe, Kazuko Taniguchi, Tanaz Petigara, Mitsuo Kaku
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 260-268 (2021)
Objectives: This study evaluated the serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates from adults (aged ≥20 years) with invasive pneumococcal disease (IPD) in Japan. Methods: This prospective observational
Externí odkaz:
https://doaj.org/article/880bc17e4bd64bfc87935e1a0363e3ce